Yüklüyor......
A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus
Type 2 diabetes (T2DM) is a chronic metabolic disorder. Impaired insulin secretion, enhanced hepatic glucose production, and suppressed peripheral glucose use are the main defects responsible for developing the disease. Besides, the pathophysiology of T2DM also includes enhanced glucagon secretion,...
Kaydedildi:
| Yayımlandı: | J Exp Pharmacol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959499/ https://ncbi.nlm.nih.gov/pubmed/32021494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S226113 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|